| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |